Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005

Rifampin-resistant Meningococcal Disease

Jean Rainbow*Comments to Author , Elizabeth Cebelinski*, Joanne Bartkus*, Anita Glennen*, Dave Boxrud*, and Ruth Lynfield*
Author affiliations: *Minnesota Department of Health, Minneapolis, Minnesota, USA

Main Article

Table 1

Rifampin phenotype and genotype of Neisseria meningitidis isolates

Strain Description Rifampin MIC (μg/mL) Amino acid change*
MDH02-2342 Sporadic rifampin-susceptible serogroup C case isolate 0.004† None (WT)
MDH02-2271 Sporadic rifampin-susceptible serogroup B case isolate <0.002† None (WT)
MDH97-498 Isolate from sporadic rifampin-resistant serogroup B case in 1996 >4,† >32‡ His552Tyr§
MDH02-2398 First sibling's isolate: rifampin susceptible, serogroup C 0.008† None (WT)
MDH02-2408 Second sibling's isolate: rifampin resistant, serogroup C >1,† >32‡ Ser548Phe§

*WT, wildtype.
†Determined by broth microdilution.
‡Determined by Etest.
§Numbering based on the entire N. meningitidis rpoB gene (GenBank accession no. Z54353). Accession numbers of isolate sequences submitted to GenBank: MDH02-2342 (AY746965), MDH02-2271 (AY746964), MDH97-498 (AY746963), MDH02-2398 (AY746966), MDH02-2408 (AY746967).

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.